The r/bioinformatics post is not a lone grievance — it is a specific structural moment [1]. When a neighboring lab's switch to a text-based tool becomes the conversational reference point inside a renewal decision, the incumbent has lost the evaluation framing. BioRender is no longer being compared against manual alternatives like PowerPoint clip art; it is being compared against tools that eliminate manual layout entirely. That is a different competitive position than the one BioRender was built to occupy.